Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

ScanSource Affirms FY2026 Sales Guidance of $3.100B-$3.300B vs $3.175B Est

Author: Benzinga Newsdesk | November 06, 2025 08:31am
ScanSource (NASDAQ:SCSC) affirms FY2026 sales outlook from $3.100 billion-$3.300 billion to $3.100 billion-$3.300 billion vs $3.175 billion estimate.

Posted In: SCSC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist